MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib ...

Phase 1b INFLO-1 study data readout anticipated in Q3 2026; DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a b ...
Health and Me on MSN

5 alarming signs your hypertension might be linked to diabetes

Both hypertension and diabetes can pose silent threats to your overall health, and when they occur together, the risks are ...